Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 From Amgen

NEXT STORY
Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
PREV STORY
Mereo BioPharma Appoints Suba Krishnan, M.D. as Senior Vice President of Clinical Development
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Autolus Therapeutics to Participate in Investor Conferences Through April

author_avatar
NASDAQ Market News

Vitamin D Supplementation Is a Critical Tool For Disease Prevention Says Dr. Ken Redcross

author_avatar
NASDAQ Market News

Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the 62nd ASH Annual Meeting

author_avatar
NASDAQ Market News